<DOC>
	<DOCNO>NCT02984787</DOCNO>
	<brief_summary>The investigator perform prospective randomize comparison 3D 2D laparoscopic total gastrectomy splenic hilum lymph node dissection .</brief_summary>
	<brief_title>3D Versus 2D Laparoscopic Total Gastrectomy With Splenic Hilum Lymph Nodes Dissection</brief_title>
	<detailed_description>A prospective randomize comparison 3D 2D laparoscopic surgery advance gastric cancer spleen-preserving splenic hilum lymph node dissection perform , evaluate safety feasibility extensive application novel 3D laparoscopic technique . The evaluation parameter number group No.10 lymph node harvest , perioperative clinical efficacy , postoperative life quality 3-year survival recurrence rate .</detailed_description>
	<criteria>1 . Primary proximal gastric adenocarcinoma confirm pathologically endoscopic biopsy ; 2. cT24aN03M0 preoperative evaluation accord AJCC Cancer Staging Manual , 7th Edition . 3 . Eastern Cooperative Oncology Group ( ECOG ) : 0 1 ; 4 . American Society Anesthesiologists （ASA） score : Ⅰto Ⅲ ; 5 . Written informed consent . 1 . Pregnant breastfeeding woman ; 2 . Severe mental disorder ; 3 . Previous upper abdominal surgery ( except laparoscopic cholecystectomy ) ; 4 . Previous gastrectomy , endoscopic mucosal resection , endoscopic submucosal dissection ; 5 . Enlarged bulky regional lymph node diameter large 3 cm base preoperative imaging ; 6 . Other malignant disease within past 5 year ; 7 . Previous neoadjuvant chemotherapy radiotherapy ; 8 . Contraindication general anesthesia ( severe cardiac and/or pulmonary disease ) ; 9 . Emergency surgery due complication ( bleeding , obstruction , perforation ) cause gastric cancer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Gastric Cancer</keyword>
	<keyword>3D</keyword>
	<keyword>2D</keyword>
</DOC>